Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Sweeping Changes Proposed for Federal Title IX Legislation

Client Alert

June 23, 2022, marked the 50th anniversary of Title IX — the federal civil rights legislation enacted to protect students from sex-based discrimination in educational programs and activities that receive federal financial assistance. The anniversary was further marked by an announcement from the Biden administration of its intent to overhaul the landmark law, in part, by reinstating certain provisions removed, or otherwise modified, by the former administration.

In conjunction with the Department of Education, President Biden announced the proposed amendments to Title IX would have the impact of advancing “educational equity and opportunity”[1] for students across the country including, without limitation, those in the LGBTQIA+ community.  Specifically, the revised regulations are anticipated to clarify Title IX’s text to extend protections to students on the basis of sexual orientation, gender identity, and sex characteristics and, moreover, extend protection to both students and employees who are pregnant and/or have pregnancy-related condition(s).

The proposed amendments would also require schools to respond promptly to all complaints of sex discrimination with a fair and reliable process that includes trained, unbiased Title IX coordinators, investigators, and decisionmakers to evaluate the evidence. Notably, the proposals would effectively remove the requirement that schools wait for a formal complaint prior to acting — thereby allowing schools to investigate and sanction sexual misconduct complaints more promptly. The proposals also allow informal resolution of an incident without the submission of a formal complaint (a formal complaint is a prerequisite under the current regulations).

Moreover, following investigation, decisionmakers may soon be subject to a revised, heightened threshold for standard of proof based on the evidence — the clear and convincing evidence standard, meaning that the evidence presented must be “highly” and substantially more probable to be true rather than untrue — depending on what standard the school uses in other comparable proceedings.

In addition to the above, the proposed regulations are generally intended to strengthen protections from retaliation for those who exercise Title IX rights, require schools to engage in and/or offer supportive measures to parties involved in Title IX actions, and improve the adaptability of the Title IX framework to be applied fully and fairly in all educational environments.

The proposed regulations also revert the definition of sexual harassment back to “unwelcome sex-based conduct that creates a hostile environment by denying or limiting a person’s ability to participate in a school’s education program or activity. This would impose significant changes to the current rule, which only prohibits unwelcome sex-based misconduct if it is “so severe, pervasive, and objectively offensive that it effectively denies a person equal access to the recipient’s education program or activity.”

Practically speaking, the proposed regulations no longer require live hearings for Title IX investigations. This is a significant change from the August 2020 regulations, which directed higher education institutions to conduct live hearings with cross-examination following the investigation. Under the August 2020 regulations, a decisionmaker was prohibited from considering any statements of parties or witnesses that were not subject to cross-examination, and therefore not tested for credibility. Ultimately, the proposed regulations, by way of eliminating the live hearing requirement, could allow decisionmakers to consider more comprehensive evidence.

To the extent a live hearing is held, the proposed regulations also require higher education institutions to allow students who participate in the live hearing to do so remotely, if they so choose.

The proposed amendments will undergo a period of public comment for the next 60 days. The Education Department will then address each point in writing before the regulations can be finalized.

[1] See U.S. Department of Justice Press Release, “The U.S. Department of Education Releases Proposed Changes to Title IX Regulations, Invites Public Comment,” published June 23, 2022.

For additional information about the revised regulations, or how they may impact your institution, please reach out to one of Brennan, Manna & Diamond’s trained Title IX investigators and advisors, Monica Andress at mbandress@bmdllc.com, Krista Warren at kdwarren@bmdllc.com, Bryan Meek at bmeek@bmdllc.com, or Matt Duncan at mrduncan@bmdllc.com.


“I’m Out Of Here!” Now What?

We all know that the healthcare industry is experiencing a wave of integration. This trend has been evident for many years. Fewer physicians are willing to assume the legal, financial and other business risks associated with owning their own practices. More and more physicians, including anesthesiologists, are becoming employed by large physician groups, health systems and national providers. This shift necessarily involves not only entry into new employment arrangements but also the termination of existing relationships. And those terminations are often governed by written employment agreements, state and federal healthcare laws and employer benefit plans and other policies and procedures. Before pursuing their next opportunity, physicians should pause for a moment and first attend to the arrangement that they are leaving. Departing physicians need to understand their legal rights and obligations when leaving their current employment relationships in order to avoid unintended consequences and detrimental missteps along the way. Here are a few words of practical advice for physicians contemplating an exit from their current employment arrangements.

Investment Training for the Second and Third Generations

Consider this scenario. Mom and Dad started the business from the ground up. Over the decades it has expanded into a money-making machine. They are able to sell the business and it results in a multimillion-dollar payday for their labors. The excess money has allowed Mom and Dad to invest with various financial advising firms, several fund management groups, and directly with new startups and joint ventures. Their experience has made them savvy investors, with a detailed understanding of how much to invest, when, and where. They cannot justify formation of a full family office with dedicated investors to manage the funds, but Mom and Dad have set up a trust fund for the children to allow these investments to continue to grow over the years. Eventually, Mom and Dad pass. Their children enjoy the fruits of their labors, and, by the time the grandchildren are adults, Mom and Dad's savvy investments are gone.

Provider Relief Funds – Continued Confusion Regarding Reporting Requirements and Lost Revenues

In Fall 2020, HHS issued multiple rounds of guidance and FAQs regarding the reporting requirements for the Provider Relief Funds, the most recently published notice being November 2, 2020 and December 11, 2020. Specifically, the reporting portal for the use of the funds in 2020 was scheduled to open on January 15, 2021. Although there was much speculation as to whether this would occur. And, as of the date of this article, the portal was not opened.

Ohio S.B. 310 Loosens Practice Barrier for Advanced Practice Providers

S.B. 310, signed by Ohio Governor DeWine and effective from December 29, 2020 until May 1, 2021, provides flexibility regarding the regulatorily mandated supervision and collaboration agreements for physician assistants, certified nurse-midwives, clinical nurse specialists and certified nurse practitioners working in a hospital or other health care facility. Originally drafted as a bill to distribute federal COVID funding to local subdivisions, the healthcare related provisions were added to help relieve some of the stresses hospitals and other healthcare facilities are facing during the COVID-19 pandemic.

HHS Issues Opinion Regarding Illegal Attempts by Drug Manufacturers to Deny 340B Discounts under Contract Pharmacy Arrangements

The federal 340B discount drug program is a safety net for many federally qualified health centers, disproportionate share hospitals, and other covered entities. This program allows these providers to obtain discount pricing on drugs which in turn allows the providers to better serve their patient populations and provide their patients with access to vital health care services. Over the years, the 340B program has undergone intense scrutiny, particularly by drug manufacturers who are required by federal law to provide the discounted pricing.